Challenges of pediatric pharmacotherapy: A narrative review of pharmacokinetics, pharmacodynamics, and pharmacogenetics
- PMID: 38078929
- DOI: 10.1007/s00228-023-03598-x
Challenges of pediatric pharmacotherapy: A narrative review of pharmacokinetics, pharmacodynamics, and pharmacogenetics
Abstract
Purpose: Personalized pharmacotherapy, including for the pediatric population, provides optimal treatment and has emerged as a major trend owing to advanced drug therapeutics and diversified drug selection. However, it is essential to understand the growth and developmental characteristics of this population to provide appropriate drug therapy. In recent years, clinical pharmacogenetics has accumulated knowledge in pediatric pharmacotherapy, and guidelines from professional organizations, such as the Clinical Pharmacogenetics Implementation Consortium, can be consulted to determine the efficacy of specific drugs and the risk of adverse effects. However, the existence of a large knowledge gap hinders the use of these findings in clinical practice.
Methods: We provide a narrative review of the knowledge gaps in pharmacokinetics (PK) and pharmacodynamics (PD) in the pediatric population, focusing on the differences from the perspective of growth and developmental characteristics. In addition, we explored PK/PD in relation to pediatric clinical pharmacogenetics.
Results: The lack of direct and indirect biomarkers for more accurate assessment of the effects of drug administration limits the current knowledge of PD. In addition, incorporating pharmacogenetic insights as pivotal covariates is indispensable in this comprehensive synthesis for precision therapy; therefore, we have provided recommendations regarding the current status and challenges of personalized pediatric pharmacotherapy. The integration of clinical pharmacogenetics with the health care system and institution of educational programs for health care providers is necessary for its safe and effective implementation. A comprehensive understanding of the physiological and genetic complexities of the pediatric population will facilitate the development of effective and personalized pharmacotherapeutic strategies.
Keywords: Pediatric pharmacotherapy; Pharmacodynamics; Pharmacogenetics; Pharmacokinetics.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Neonatal clinical pharmacology.Paediatr Anaesth. 2014 Jan;24(1):30-8. doi: 10.1111/pan.12176. Epub 2013 Apr 26. Paediatr Anaesth. 2014. PMID: 23617305 Free PMC article. Review.
-
Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics.Clin Pharmacokinet. 2016 May;55(5):507-24. doi: 10.1007/s40262-015-0328-5. Clin Pharmacokinet. 2016. PMID: 26410689 Free PMC article. Review.
-
Clinical implementation of pharmacogenetics and model-informed precision dosing to improve patient care.Br J Clin Pharmacol. 2022 Feb;88(4):1418-1426. doi: 10.1111/bcp.14426. Epub 2020 Jul 8. Br J Clin Pharmacol. 2022. PMID: 32529759 Review.
-
Obstetric therapeutics-how pharmacogenetics may inform drug therapy for pregnant women in the future.Obstet Gynecol Surv. 2013 Sep;68(9):650-4. doi: 10.1097/OGX.0b013e3182a66180. Obstet Gynecol Surv. 2013. PMID: 25102121 Review.
-
Pharmacogenomics in Pain Management: A Review of Relevant Gene-Drug Associations and Clinical Considerations.Ann Pharmacother. 2021 Dec;55(12):1486-1501. doi: 10.1177/10600280211003875. Epub 2021 Mar 26. Ann Pharmacother. 2021. PMID: 33771051 Review.
References
-
- Rieder M (2019) Pharmacy and pediatric drug therapy: the key to safe and effective treatment for children. Am J Health Syst Pharm 76:1452–1453. https://doi.org/10.1093/ajhp/zxz171 - DOI - PubMed
-
- Meyers RS, Thackray J, Matson KL et al (2020) Key potentially inappropriate drugs in pediatrics: the KIDs list. J Pediatr Pharmacol Ther 25:175–191. https://doi.org/10.5863/1551-6776-25.3.175 - DOI - PubMed - PMC
-
- Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279:1200–1205. https://doi.org/10.1001/jama.279.15.1200 - DOI - PubMed
-
- Giardina C, Cutroneo PM, Mocciaro E et al (2018) Adverse drug reactions in hospitalized patients: results of the FORWARD (Facilitation of Reporting in Hospital Ward) study. Front Pharmacol 9:350. https://doi.org/10.3389/fphar.2018.00350 - DOI - PubMed - PMC
-
- Tripathy R, Das S, Das P et al (2021) Adverse drug reactions in the pediatric population: findings from the adverse drug reaction monitoring center of a teaching hospital in Odisha (2015–2020). Cureus 13:e19424. https://doi.org/10.7759/cureus.19424 - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous